The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...
Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...